Literature DB >> 20876543

Malignant biliary tract obstruction: evaluation and therapy.

David Chu1, Douglas G Adler.   

Abstract

Malignant biliary tract obstruction is a common clinical entity. Patients with tumors causing biliary tract obstruction are often asymptomatic until disease is significantly advanced. Symptoms of obstructive jaundice can significantly impair quality-of-life unless intervention to decompress the biliary tract, either curative or palliative, is performed. This article reviews the evaluation and management of patients with malignant biliary tract obstruction, including the available imaging and treatment modalities (endoscopic, percutaneous, and surgical approach) for relieving malignant biliary tract obstruction.

Entities:  

Mesh:

Year:  2010        PMID: 20876543     DOI: 10.6004/jnccn.2010.0075

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  11 in total

1.  Role of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in isolated pancreatic metastasis from lung cancer.

Authors:  Dushyant Singh; Omkar U Vaidya; Esmat Sadeddin; Osama Yousef
Journal:  World J Gastrointest Endosc       Date:  2012-07-16

2.  Prognostic relevance of circulating CK19 mRNA in advanced malignant biliary tract diseases.

Authors:  Kawin Leelawat; Siriluck Narong; Wandee Udomchaiprasertkul; Jerasak Wannaprasert; Sa-ard Treepongkaruna; Somboon Subwongcharoen; Tawee Ratanashu-ek
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

3.  Role of Percutaneous Transhepatic Biliary Drainage as an Adjunct to Endoscopic Retrograde Cholangiopancreatography.

Authors:  Nikita Verma; Hema H K; Pankaj Gupta; Mandeep Kang; Naveen Kalra; Jayanta Samanta; Harshal Mandavdhare; Vishal Sharma; Usha Dutta; Rakesh Kochhar; Manavjit S Sandhu
Journal:  J Clin Exp Hepatol       Date:  2021-09-10

4.  Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management.

Authors:  Borui Pi; Jin Wang; Yifan Tong; Qiao Yang; Fangfang Lv; Yunsong Yu
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-12-01       Impact factor: 2.586

5.  Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents.

Authors:  Charles Edouard Zurstrassen; Almir Galvão Vieira Bitencourt; Marcos Duarte Guimaraes; Aline Cristine Barbosa Santos Cavalcante; Chiang Jeng Tyng; Mauricio Kauark Amoedo; João Paulo Kawaoka Matsushita Junior; Janio Szklaruk; Edson Marchiori; Rubens Chojniak
Journal:  Radiol Bras       Date:  2017 Mar-Apr

6.  The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study.

Authors:  James Rees; Jemma Mytton; Felicity Evison; Kamarjit Singh Mangat; Prashant Patel; Nigel Trudgill
Journal:  BMJ Open       Date:  2020-01-23       Impact factor: 2.692

7.  Percutaneous transhepatic biliary stent placement in the palliative management of malignant obstructive jaundice: initial experience in a tertiary center in Ghana.

Authors:  Benjamin Dabo Sarkodie; Benard Ohene Botwe; Edmund Kwadwo Kwakye Brakohiapa
Journal:  Pan Afr Med J       Date:  2020-09-27

8.  The impact of preoperative biliary drainage on postoperative outcomes in patients with malignant obstructive jaundice: a retrospective analysis of 290 consecutive cases at a single medical center.

Authors:  Zhihui Gao; Jie Wang; Sheng Shen; Xiaobo Bo; Tao Suo; Xiaoling Ni; Han Liu; Lihong Huang; Houbao Liu
Journal:  World J Surg Oncol       Date:  2022-01-06       Impact factor: 2.754

9.  Therapeutic biliary and pancreatic endoscopy in Qatar- a five year retrospective audit.

Authors:  Anil John; Khalid Mattar; Anjum Susan John; Mohammed Khairat; Saad Al Kaabi
Journal:  Qatar Med J       Date:  2013-11-01

10.  Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands.

Authors:  N Haj Mohammad; N Bernards; M G H Besselink; O R Busch; J W Wilmink; G J M Creemers; I H J T De Hingh; V E P P Lemmens; H W M van Laarhoven
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.